Lili Gong

2.1k total citations
87 papers, 1.6k citations indexed

About

Lili Gong is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Lili Gong has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 16 papers in Pharmacology and 14 papers in Cancer Research. Recurrent topics in Lili Gong's work include Metabolomics and Mass Spectrometry Studies (6 papers), Pharmacological Effects of Natural Compounds (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Lili Gong is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (6 papers), Pharmacological Effects of Natural Compounds (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Lili Gong collaborates with scholars based in China, United States and Saudi Arabia. Lili Gong's co-authors include Yali Lv, Lihong Liu, Feifei Han, Zirui Wan, Guanhua Du, Lihong Liu, Lingling Xuan, Lian‐Hua Fang, Song Yang and He Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Lili Gong

80 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Gong China 26 693 203 190 188 160 87 1.6k
Yuan‐Yen Chang Taiwan 29 746 1.1× 303 1.5× 186 1.0× 174 0.9× 158 1.0× 81 2.0k
Jie Su China 26 1.1k 1.6× 191 0.9× 141 0.7× 194 1.0× 246 1.5× 133 2.1k
Hyesook Lee South Korea 23 777 1.1× 128 0.6× 151 0.8× 161 0.9× 121 0.8× 87 1.6k
Haiming Shi China 24 966 1.4× 130 0.6× 175 0.9× 105 0.6× 222 1.4× 101 1.9k
Zhou‐Yan Bian China 31 1.1k 1.6× 189 0.9× 163 0.9× 163 0.9× 258 1.6× 63 2.2k
Alireza Garjani Iran 28 810 1.2× 233 1.1× 331 1.7× 138 0.7× 160 1.0× 103 2.2k
Dapeng Chen China 24 1.0k 1.5× 170 0.8× 186 1.0× 120 0.6× 230 1.4× 67 2.0k
Mun-Ock Kim South Korea 23 956 1.4× 95 0.5× 210 1.1× 247 1.3× 194 1.2× 59 1.7k
Hao Guo China 24 953 1.4× 138 0.7× 275 1.4× 311 1.7× 271 1.7× 91 2.1k
Shuang Jiang China 27 972 1.4× 228 1.1× 166 0.9× 111 0.6× 123 0.8× 65 1.7k

Countries citing papers authored by Lili Gong

Since Specialization
Citations

This map shows the geographic impact of Lili Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Gong more than expected).

Fields of papers citing papers by Lili Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Gong. The network helps show where Lili Gong may publish in the future.

Co-authorship network of co-authors of Lili Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Gong. A scholar is included among the top collaborators of Lili Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Gong. Lili Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoxue, et al.. (2025). Metabolomics approach reveals key plasma biomarkers in multiple myeloma for diagnosis, staging, and prognosis. Journal of Translational Medicine. 23(1). 163–163. 1 indexed citations
2.
Chen, Long, Peng Wei, Xiaoxu Kang, et al.. (2024). In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment. ACS Applied Materials & Interfaces. 16(37). 49013–49029. 1 indexed citations
3.
Zhao, Yan, Lei Zhao, Maocai Li, et al.. (2024). Long non-coding RNA PVT1 regulates TGF-β and promotes the proliferation, migration and invasion of hypopharyngeal carcinoma FaDu cells. World Journal of Surgical Oncology. 22(1). 254–254. 2 indexed citations
4.
Gong, Lili, et al.. (2024). Diagnosis and Analysis of Vasa Previa Types With Flow HD Glass Body. Journal of Ultrasound in Medicine. 44(2). 189–194. 1 indexed citations
5.
Gong, Lili, Ruixin Liu, Lihua Wang, et al.. (2023). A novel HClO-activatable lysosome-targeted fluorescent probe for imaging and diagnosis of atherosclerosis. Microchemical Journal. 196. 109694–109694. 12 indexed citations
6.
Wang, Xumei, et al.. (2023). Screening of H2S donors with a red emission mitochondria-targetable fluorescent probe: Toward discovering a new therapeutic strategy for Parkinson's disease. Biosensors and Bioelectronics. 237. 115521–115521. 36 indexed citations
7.
Li, Pengfei, Jun Peng, Yuexin Li, et al.. (2021). Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Causes of the Ultra-Low Oral Bioavailability and Metabolic Pathway. Frontiers in Pharmacology. 12. 621003–621003. 10 indexed citations
8.
Wang, Yanyan, Qinghua Cui, Lili Gong, et al.. (2020). Screening for Anti‐Influenza Actives of Prefractionated Traditional Chinese Medicines. Evidence-based Complementary and Alternative Medicine. 2020(1). 4979850–4979850. 8 indexed citations
9.
Han, Feifei, Lulu Ren, Lingling Xuan, et al.. (2020). HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer. Cancer Chemotherapy and Pharmacology. 87(1). 103–112. 4 indexed citations
10.
11.
Gong, Lili, et al.. (2016). MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor. SHILAP Revista de lepidopterología. 4 indexed citations
12.
Lv, Yali, Feifei Han, Lili Gong, et al.. (2016). Human cytomegalovirus infection and vascular disease risk: A meta-analysis. Virus Research. 227. 124–134. 15 indexed citations
13.
Gong, Lili, et al.. (2016). Analysis on volatile flavor compounds of fermented grains by SAFE and HS-SPME coupled with GC-MS. 42(9). 177. 3 indexed citations
14.
Jiang, Haiqiang, Jianqing Ju, Yunlun Li, et al.. (2015). A metabolomic study using HPLC–TOF/MS coupled with ingenuity pathway analysis: Intervention effects of Rhizoma Alismatis on spontaneous hypertensive rats. Journal of Pharmaceutical and Biomedical Analysis. 117. 446–452. 24 indexed citations
15.
Li, Lianqing, Jing Wang, Lei Gao, & Lili Gong. (2015). Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.. PubMed. 8(8). 9232–9. 14 indexed citations
16.
Han, Feifei, et al.. (2014). Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft. Transplant Immunology. 31(2). 81–86. 17 indexed citations
17.
Gong, Lili, Lian‐Hua Fang, Heyao Wang, et al.. (2013). Genetic risk factors for glucocorticoid-induced osteonecrosis: A meta-analysis. Steroids. 78(4). 401–408. 27 indexed citations
18.
Gong, Lili. (2012). GC-MS Combined with Kovats Index Analysis for Volatile Compounds in Hedyoti diffusae. Zhongguo shiyan fangjixue zazhi. 2 indexed citations
19.
Gong, Lili, Lian‐Hua Fang, Hai‐Lin Qin, Yang Lv, & Guanhua Du. (2012). Analysis of the Mechanisms Underlying the Vasorelaxant Action of Coptisine in Rat Aortic Rings. The American Journal of Chinese Medicine. 40(2). 309–320. 15 indexed citations
20.
Gong, Lili, et al.. (2010). Ginsenoside Rg2 attenuates learning and memory loss through an anti-apoptotic property in a rat model of multi-infarct dementia. 10(6). 1069–1075. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan‐Yen Chang Breakdown of academic impact, for papers by Jie Su Breakdown of academic impact, for papers by Hyesook Lee Breakdown of academic impact, for papers by Haiming Shi Breakdown of academic impact, for papers by Zhou‐Yan Bian Breakdown of academic impact, for papers by Alireza Garjani Breakdown of academic impact, for papers by Dapeng Chen Breakdown of academic impact, for papers by Mun-Ock Kim Breakdown of academic impact, for papers by Hao Guo Breakdown of academic impact, for papers by Shuang Jiang
Rankless by CCL
2026